Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature / Alessandro Picelli in Annals of physical and rehabilitation medicine, Vol. 62, n°4 (Juillet 2019)  

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 291-296 Titre : Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature Type de document : texte imprimé Auteurs : Alessandro Picelli ; Andrea Santamato ; Elena Chemello ; Nicoletta Cinone ; Carlo Cisari ; Marialuisa Gandolfi ; Maurizio Ranieri ; Alessio Baricich Année de publication : 2019 Article en page(s) : p. 291-296 Note générale : doi.org/10.1016/j.rehab.2018.08.004 Langues : Anglais (eng) Mots-clés : Botulinum toxins  Muscle spasticity  Physical therapy modalities  Rehabilitation Résumé : Background and objective A wide range of adjunct therapies after botulinum toxin administration have been proposed. The aim of the present paper is to provide an overview of major writings dealing with adjuvant (non-pharmacological) treatments associated with botulinum toxin for managing spasticity in order to provide some up-to-date information about the usefulness of the most commonly used procedures. Methods The literature in PubMed was searched with the MeSH terms botulinum toxins, muscle spasticity, physical therapy modalities, and rehabilitation. The results were limited to studies focusing on adjuvant treatments associated with botulinum toxin for managing spasticity. We excluded papers on the use of non-drug treatments for spasticity not associated with botulinum toxin serotype A (BoNT-A) injection. Relevant literature known to the authors along with this complementary search represented the basis for this overview of the literature. Results Adhesive taping and casting effectively improved the botulinum toxin effect in patients with upper- and lower-limb spasticity. There is level 1 evidence that casting is better than taping for outcomes including spasticity, range of motion and gait. However, consensus about their most appropriate timing, duration, target and material is lacking. In terms of physical modalities combined with botulinum toxin injection, we found level 1 evidence that extracorporeal shock wave therapy is better than electrical stimulation for some post-injection outcomes including spasticity and pain. Furthermore, electrical stimulation of injected muscles might be useful to boost the toxin effect. However, the best stimulation protocol has not been defined. In addition, we found level 2b evidence that whole-body vibration therapy might reduce spasticity with cerebral palsy. Conclusion Future research in this field should focus on investigating the most appropriate post-injection treatment protocol for each goal to achieve. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065718314453 Permalink : ./index.php?lvl=notice_display&id=84134 [article] Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature [texte imprimé] / Alessandro Picelli ; Andrea Santamato ; Elena Chemello ; Nicoletta Cinone ; Carlo Cisari ; Marialuisa Gandolfi ; Maurizio Ranieri ; Alessio Baricich . - 2019 . - p. 291-296. doi.org/10.1016/j.rehab.2018.08.004 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 291-296 Mots-clés : Botulinum toxins  Muscle spasticity  Physical therapy modalities  Rehabilitation Résumé : Background and objective A wide range of adjunct therapies after botulinum toxin administration have been proposed. The aim of the present paper is to provide an overview of major writings dealing with adjuvant (non-pharmacological) treatments associated with botulinum toxin for managing spasticity in order to provide some up-to-date information about the usefulness of the most commonly used procedures. Methods The literature in PubMed was searched with the MeSH terms botulinum toxins, muscle spasticity, physical therapy modalities, and rehabilitation. The results were limited to studies focusing on adjuvant treatments associated with botulinum toxin for managing spasticity. We excluded papers on the use of non-drug treatments for spasticity not associated with botulinum toxin serotype A (BoNT-A) injection. Relevant literature known to the authors along with this complementary search represented the basis for this overview of the literature. Results Adhesive taping and casting effectively improved the botulinum toxin effect in patients with upper- and lower-limb spasticity. There is level 1 evidence that casting is better than taping for outcomes including spasticity, range of motion and gait. However, consensus about their most appropriate timing, duration, target and material is lacking. In terms of physical modalities combined with botulinum toxin injection, we found level 1 evidence that extracorporeal shock wave therapy is better than electrical stimulation for some post-injection outcomes including spasticity and pain. Furthermore, electrical stimulation of injected muscles might be useful to boost the toxin effect. However, the best stimulation protocol has not been defined. In addition, we found level 2b evidence that whole-body vibration therapy might reduce spasticity with cerebral palsy. Conclusion Future research in this field should focus on investigating the most appropriate post-injection treatment protocol for each goal to achieve. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065718314453 Permalink : ./index.php?lvl=notice_display&id=84134

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

Blurred lines between axillary web syndrome and Mondor's disease after breast cancer surgery : A case report / Allessandro de Sire in Annals of physical and rehabilitation medicine, Vol. 63, n°4 (Juillet 2020)

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 63, n°4 (Juillet 2020) . - p. 365-367 Titre : Blurred lines between axillary web syndrome and Mondor's disease after breast cancer surgery : A case report Type de document : texte imprimé Auteurs : Allessandro de Sire ; Marco Invernizzi ; Lorenzo Lippi ; Carlo Cisari ; Levent Özçakar ; Franco Franchignoni Année de publication : 2020 Article en page(s) : p. 365-367 Note générale : doi.org/10.1016/j.rehab.2019.04.007 Langues : Anglais (eng) Mots-clés : Axillary web syndrome  Mondor's disease  Breast cancer  Ultrasonography  Rehabilitation Permalink : ./index.php?lvl=notice_display&id=90884 [article] Blurred lines between axillary web syndrome and Mondor's disease after breast cancer surgery : A case report [texte imprimé] / Allessandro de Sire ; Marco Invernizzi ; Lorenzo Lippi ; Carlo Cisari ; Levent Özçakar ; Franco Franchignoni . - 2020 . - p. 365-367. doi.org/10.1016/j.rehab.2019.04.007 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 63, n°4 (Juillet 2020) . - p. 365-367 Mots-clés : Axillary web syndrome  Mondor's disease  Breast cancer  Ultrasonography  Rehabilitation Permalink : ./index.php?lvl=notice_display&id=90884

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study / Alessio Baricich in Annals of physical and rehabilitation medicine, Vol. 62, n°4 (Juillet 2019)  

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 214-219 Titre : Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study Type de document : texte imprimé Auteurs : Alessio Baricich ; Alessandro Picelli ; Stefano Carda ; Nicola Smania ; Carlo Cisari ; Andrea Santamato ; Allessandro de Sire ; Marco Invernizzi Année de publication : 2019 Article en page(s) : p. 214-219 Note générale : https://doi.org/10.1016/j.rehab.2019.06.002 Langues : Anglais (eng) Mots-clés : Stroke  Spasticity  Botulinum toxin type A  Electrical stimulation  Rehabilitation Résumé : Background Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and should be offered as first-line treatment for focal manifestations. Although its possible role has been hypothesized, the efficacy of electrical stimulation (ES) of antagonists of the injected muscles for improving clinical outcome after BoNT-A injection remains to be established. Objectives This randomized single-blind pilot study aimed to investigate the efficacy of ES of antagonist muscles as adjunct treatment after BoNT-A injection to plantar flexor muscles in hemiplegic patients with spastic equinus foot. Methods After BoNT-A injection at triceps surae, patients were randomly allocated to 2 groups: group 1, single ES session on injected muscles plus 5 sessions of ES on antagonist muscles, and group 2, single ES session on injected muscles alone. Both groups underwent daily physical therapy for 60 min for 2 weeks (5 days/week). Assessments were performed before treatment (T0) and at 10 days (T1), 20 days (T2), and 90 days (T3) after treatment. Our primary outcome was gait velocity at a comfortable speed at T2 (10-m walk test [10MWT]). The following were secondary outcomes: triceps surae spasticity (Modified Ashworth Scale), ankle passive range of motion (pROM), strength of tibialis anterior muscle, and 2-min walk test (2MWT). Results The 30 patients enrolled were randomly allocated to the 2 groups: 15 in group 1 and 15 in group 2. At T1, T2 and T3, both groups showed a significant reduction in muscle tone and an increase in ankle pROM (P < 0.05). At T2 and T3, both groups showed a significant increase in 10MWT and 2MWT. The groups did not significantly differ in tibialis anterior strength or primary or secondary outcome measures. Conclusions ES of antagonist muscles does not improve clinical outcomes in the post-stroke spastic equinus foot after BoNT-A injection. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065719300752 Permalink : ./index.php?lvl=notice_display&id=84125 [article] Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study [texte imprimé] / Alessio Baricich ; Alessandro Picelli ; Stefano Carda ; Nicola Smania ; Carlo Cisari ; Andrea Santamato ; Allessandro de Sire ; Marco Invernizzi . - 2019 . - p. 214-219. https://doi.org/10.1016/j.rehab.2019.06.002 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 214-219 Mots-clés : Stroke  Spasticity  Botulinum toxin type A  Electrical stimulation  Rehabilitation Résumé : Background Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and should be offered as first-line treatment for focal manifestations. Although its possible role has been hypothesized, the efficacy of electrical stimulation (ES) of antagonists of the injected muscles for improving clinical outcome after BoNT-A injection remains to be established. Objectives This randomized single-blind pilot study aimed to investigate the efficacy of ES of antagonist muscles as adjunct treatment after BoNT-A injection to plantar flexor muscles in hemiplegic patients with spastic equinus foot. Methods After BoNT-A injection at triceps surae, patients were randomly allocated to 2 groups: group 1, single ES session on injected muscles plus 5 sessions of ES on antagonist muscles, and group 2, single ES session on injected muscles alone. Both groups underwent daily physical therapy for 60 min for 2 weeks (5 days/week). Assessments were performed before treatment (T0) and at 10 days (T1), 20 days (T2), and 90 days (T3) after treatment. Our primary outcome was gait velocity at a comfortable speed at T2 (10-m walk test [10MWT]). The following were secondary outcomes: triceps surae spasticity (Modified Ashworth Scale), ankle passive range of motion (pROM), strength of tibialis anterior muscle, and 2-min walk test (2MWT). Results The 30 patients enrolled were randomly allocated to the 2 groups: 15 in group 1 and 15 in group 2. At T1, T2 and T3, both groups showed a significant reduction in muscle tone and an increase in ankle pROM (P < 0.05). At T2 and T3, both groups showed a significant increase in 10MWT and 2MWT. The groups did not significantly differ in tibialis anterior strength or primary or secondary outcome measures. Conclusions ES of antagonist muscles does not improve clinical outcomes in the post-stroke spastic equinus foot after BoNT-A injection. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065719300752 Permalink : ./index.php?lvl=notice_display&id=84125

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

---

1 (1 - 3 / 3)